Drug intelligence / Profile preview

tribenoside

Development stage
Phase 3
Lead developer
Recordati
Modality
Small Molecules
Administration
Oral, Topical, Rectal
01

Overview

Tribenoside is a small molecule vasoprotective and anti-inflammatory drug primarily used for the treatment of hemorrhoids and venous circulation disorders such as varicose veins and phlebitis[1][2][3][4]. It exhibits mild anti-inflammatory, analgesic, wound-healing, antitoxic, fibrinolysis-promoting, membrane-stabilizing, and venotropic properties[6][8]. Tribenoside acts by reducing vascular permeability and causing vasoconstriction. Mechanistically, it antagonizes inflammatory mediators including histamine, serotonin (5-HT), bradykinin and others[3]. It also stimulates laminin α5 production and laminin-332 deposition to support basement membrane repair during wound healing[1]. Unlike corticosteroids or NSAIDs it does not adversely affect the gastrointestinal tract or immune system[6][8]. Tribenoside is often formulated in combination with lidocaine for topical use in hemorrhoid management under brand names such as Procto-Glyvenol[5][8].

Brand names
GlyvenolProcto-Glyvenol
Other names
(3R,4R,5R)-4-(Benzyloxy)-5-[1,2-bis(benzyloxy)ethyl]-2-ethoxyoxolan-3-olO-benzyl-D-glucofuranoside
02

Targets

Bradykinin B2 receptorH (Histamine receptors)5-HT (Serotonin receptors)

Beyond the preview

Go deeper on tribenoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tribenoside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call